Clinical Trials Directory

Trials / Unknown

UnknownNCT05985174

Role of Neutrophil CD64 and Monocyte HLA-DR Markers in the Dignosis of Neonatal Sepsis

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Sohag University · Academic / Other
Sex
All
Age
1 Day – 28 Days
Healthy volunteers
Not accepted

Summary

Neonatal septicemia remains one of the main causes of neonatal morbidity and mortality . Sepsis which is caused by a dysregulated host response to an infectious trigger leading to a life threatening organ dysfunction was declared by the World Health Organization (WHO) on May 2017 as a global health priority that requires resolution for its prevention , dignosis , and management (Monneret et al., 2019). Despite the advances in perinatal and neonatal sepsis remains high and the outcome is still sever (Chirio et al.,2011) . HLA-DR is on the surface of monocyte \\ macrophages , dendritic cells, and B cells and plays a crucial role in adaptive immune response , More than 30 years ago , researches proved an association between the low level of HLA-DR and the development of sepsis (Cheadle at al .,1991) . A decreased expression of mHLA-DR molecules has been associated with immunoparalysis , which is an inflammatory immune responce that occurs in sepsis .(Pradhan et al.,2016).

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTCD64 , HLA-DRCD64 is atype of integral membrane glycoprotein , when activated , it increases the neutrophils' potential for phagocytosis and bacterial killing . HLA-DR is on the surface of monocyte\\macrophages , dendritic cells and plays a crucial role in adaptive immune response

Timeline

Start date
2023-08-01
Primary completion
2024-08-01
Completion
2024-08-01
First posted
2023-08-14
Last updated
2023-08-14

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05985174. Inclusion in this directory is not an endorsement.